Health
Icosavax Launches COVID-19 Vaccine Program with Preclinical Data and $16.5 Million in New Funding | Vaccines | News Channels – PipelineReview.com
La Merie Publishing prepares brief and full reports as well as competitor analysis reports, the latter in a tabulated format with structured listings of industry-relevant…
Details
Category: Vaccines
Published on Saturday, 31 October 2020 11:49
Hits: 212
Preclinical data published in Cell show the company’s COVID-19 vaccine candidate induces high neutralizing antibody titers after a single administration
SEATTLE, WA, USA I October 30, 2020 IIcosavax, Inc. today announced the launch of the company’s COVID-19 vaccine program with preclinical data on the company’s VLP vaccine candidate, IVX-411, which comprises a virus-like particle (VLP) displaying the SARS-CoV-2 receptor-binding…
-
Noosa News23 hours agoAbusive bus driver fired by council loses appeal
-
General19 hours agoIran’s currency at record low as tensions run high
-
Noosa News23 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home
-
General12 hours agoTexas opens probe into Kellogg’s health claims, dyes